A PAT Solution for Automated Mill Control - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

A PAT Solution for Automated Mill Control
The authors describe the implementation of an on-line particle-size analyzer on an active pharmaceutical ingredient milling operation at a commercial site.


Pharmaceutical Technology
Volume 34, Issue 1

Assessing the analytical solution


Figure 5: Real-time trend showing the impact of blade-rotation speed on particle size.
Following installation of the analyzer and optimization of the process interface, real-time particle-size data became available. In an initial study, the sensitivity of the analytical solution was investigated by systematically varying mill speed. Figure 5 shows data measured as rotor speed was changed between 2600 and 4000 rpm. The overlaid results (not shown) demonstrate the ability of the system to detect the impact of changes as small as 50 rpm, just 1.5% of the controlled variable range. With such a short trial, segregation of the mill feed can be a complicating factor, so under normal operating conditions, sensitivity is expected to be even higher.


Figure 6: Off- and on-line measurement of particle size as a function of mill rotor speed.
Although sensitivity is arguably the most relevant issue for process control, accuracy is also important. For this application, the off-line reference method used for in-process testing is a wet laser-diffraction measurement with a Malvern Mastersizer 2000 (Hydro S accessory), so a comparative study was carried out using this technique (see Figure 6). Analytical data were compared across the full operational range by manually extracting a sample for off-line analysis during each stable period of the variable speed trial previously described.


Figure 7: Correlation plot of on-line Dv50 (Insitec) versus off-line Dv50 (Mastersizer 2000). R2 = 0.9417.
The results show that both analytical methods successfully detect decreasing particle size as the blade speed increases. However, the on-line system gives a smoother correlation that more accurately reflects the expected trend. It exhibits better stability and greater sensitivity, highlighting the benefits of embedded analysis compared with an off-line method. Despite the short run time and the sampling errors introduced by manual analysis, it is possible to demonstrate a very stable correlation between off- and on-line results as shown in Figure 7.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here